201 related articles for article (PubMed ID: 36703136)
1. H3K4me3 mediates uterine leiomyoma pathogenesis via neuronal processes, synapsis components, proliferation, and Wnt/β-catenin and TGF-β pathways.
Carbajo-García MC; Juarez-Barber E; Segura-Benítez M; Faus A; Trelis A; Monleón J; Carmona-Antoñanzas G; Pellicer A; Flanagan JM; Ferrero H
Reprod Biol Endocrinol; 2023 Jan; 21(1):9. PubMed ID: 36703136
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles.
Carbajo-García MC; Corachán A; Juárez-Barber E; Monleón J; Payá V; Trelis A; Quiñonero A; Pellicer A; Ferrero H
J Pathol; 2022 Aug; 257(5):663-673. PubMed ID: 35472162
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Role of Histone Modifications in Uterine Leiomyoma: Acetylation of H3K27 Regulates the Expression of Genes Involved in Proliferation, Cell Signaling, Cell Transport, Angiogenesis and Extracellular Matrix Formation.
Carbajo-García MC; de Miguel-Gómez L; Juárez-Barber E; Trelis A; Monleón J; Pellicer A; Flanagan JM; Ferrero H
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740301
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
Corachán A; Ferrero H; Aguilar A; Garcia N; Monleon J; Faus A; Cervelló I; Pellicer A
Fertil Steril; 2019 Feb; 111(2):397-407. PubMed ID: 30458994
[TBL] [Abstract][Full Text] [Related]
6. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.
Ono M; Yin P; Navarro A; Moravek MB; Coon JS; Druschitz SA; Serna VA; Qiang W; Brooks DC; Malpani SS; Ma J; Ercan CM; Mittal N; Monsivais D; Dyson MT; Yemelyanov A; Maruyama T; Chakravarti D; Kim JJ; Kurita T; Gottardi CJ; Bulun SE
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17053-8. PubMed ID: 24082114
[TBL] [Abstract][Full Text] [Related]
7. 5-aza-2'-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas.
Carbajo-García MC; Corachán A; Segura-Benitez M; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Reprod Biol Endocrinol; 2021 Jul; 19(1):106. PubMed ID: 34233687
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits stem cell proliferation in human leiomyoma via TGF-β3 and Wnt/β-Catenin pathways.
Afrin S; Ali M; El Sabeh M; Yang Q; Al-Hendy A; Borahay MA
J Cell Mol Med; 2022 Mar; 26(5):1684-1698. PubMed ID: 35118811
[TBL] [Abstract][Full Text] [Related]
10. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
Yang Q; Mas A; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306
[TBL] [Abstract][Full Text] [Related]
11. SATB2 and NGR1: potential upstream regulatory factors in uterine leiomyomas.
Sato S; Maekawa R; Tamura I; Shirafuta Y; Shinagawa M; Asada H; Taketani T; Tamura H; Sugino N
J Assist Reprod Genet; 2019 Nov; 36(11):2385-2397. PubMed ID: 31728810
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin Inhibits Wnt/β-Catenin Pathway in Uterine Leiomyoma.
El Sabeh M; Saha SK; Afrin S; Borahay MA
Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34614511
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signaling pathway in uterine leiomyoma: role in tumor biology and targeting opportunities.
El Sabeh M; Saha SK; Afrin S; Islam MS; Borahay MA
Mol Cell Biochem; 2021 Sep; 476(9):3513-3536. PubMed ID: 33999334
[TBL] [Abstract][Full Text] [Related]
15. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas.
Moyo MB; Parker JB; Chakravarti D
Nat Commun; 2020 Feb; 11(1):1019. PubMed ID: 32094355
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.
Maekawa R; Sato S; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Takaki E; Nakai A; Sugino N
PLoS One; 2013; 8(6):e66632. PubMed ID: 23818951
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.
Navarro A; Yin P; Monsivais D; Lin SM; Du P; Wei JJ; Bulun SE
PLoS One; 2012; 7(3):e33284. PubMed ID: 22428009
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis reveals candidate mRNA and their potential roles in uterine leiomyomas.
Xia L; Liu Y; Fu Y; Dongye S; Wang D
J Obstet Gynaecol Res; 2017 Jan; 43(1):149-156. PubMed ID: 27987347
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice.
Tanwar PS; Lee HJ; Zhang L; Zukerberg LR; Taketo MM; Rueda BR; Teixeira JM
Biol Reprod; 2009 Sep; 81(3):545-52. PubMed ID: 19403928
[TBL] [Abstract][Full Text] [Related]
20. Classical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas.
Tai CT; Lin WC; Chang WC; Chiu TH; Chen GT
Mol Reprod Dev; 2003 Feb; 64(2):172-8. PubMed ID: 12506349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]